echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature's new achievement solves ten-year mystery and analyzes the structure of key proteins in Parkinson's disease

    Nature's new achievement solves ten-year mystery and analyzes the structure of key proteins in Parkinson's disease

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Australian researchers have recently solved a multi-year mystery about Parkinson's disease


    For the first time, researchers took a "real scene" shot of a protein called PINK1


    This discovery is the new result of an eight-year project and provides the first detailed blueprint for the discovery and development of therapeutic drugs to slow the development of Parkinson's disease


    Switch off

    Parkinson's disease is a progressive neurodegenerative disease caused by the death of dopamine-producing cells in the brain


    Zhong Yan Gan said that this study provides an unprecedented perspective to better understand the PINK1 protein, which plays a key role in early-onset Parkinson's disease


    "What we did was take a series of snapshots of proteins, and then stitch them together to make a'real scene' movie to reveal the activation process of PINK1


    PINK1 marks damaged mitochondria to be destroyed and recovered, thereby protecting cells


    Zhong Yan Gan said: “An important discovery of ours is that PINK1 forms a dimer, which is essential for initiating or activating proteins to perform their functions


    Drug discovery

    Professor Komander said these results paved the way for the development of therapeutic drugs that "turn on" PINK1 to treat Parkinson's disease


    Failure of PINK1 or other components in the pathway is considered a key feature of some cases of Parkinson's disease


    Walter and Dr.


    Dr.


    ###

    Gan, ZY, Callegari, S.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.